Abstract:Background: The currently used conventional susceptibility testing for drug-resistant Mycobacterium tuberculosis (M.TB) is limited due to being time-consuming and having low efficiency. Herein, we propose the use of a microfluidic-based method to rapidly detect drug-resistant gene mutations using Kompetitive Allele-Specific PCR (KASP).Methods: A total of 300 clinical samples were collected, and DNA extraction was performed using the "isoChip & REG;" Mycobacterium detection kit. Phenotypic susceptibility testing and Sanger sequencing were performed to sequence the PCR products. Allele-specific primers targeting 37 gene mutation sites were designed, and a microfluidic chip (KASP) was constructed using 112 reaction chambers to simultaneously detect multiple mutations. Chip validation was performed using clinical samples.Results: Phenotypic susceptibility of clinical isolates revealed 38 rifampicin (RIF)-resistant, 64 isoniazid (INH)-resistant, 48 streptomycin (SM)-resistant and 23 ethambutol (EMB)-resistant strains, as well as 33 multi-drug-resistant TB (MDR-TB) strains and 20 strains fully resistant to all four drugs. Optimization of the chip-based detection system for drug resistance detection showed satisfactory specificity and maximum fluorescence at a DNA concentration of 1x101 copies/& mu;L. Further analysis revealed that 76.32% of the RIF-resistant strains harbored rpoB gene mutations (sensitivity, 76.32%; specificity 100%), 60.93% of the INH-resistant strains had katG gene mutations (sensitivity, 60.93%; specificity, 100%), 66.66% of the SM-resistant strains carried drug resistance gene mutations (sensitivity, 66.66%; specificity, 99.2%), and 69.56% of the EMB-resistant strains had embB gene mutations (sensitivity, 69.56%; specificity, 100%). Further, the overall agreement between the microfluidic chip and Sanger sequencing was satisfactory, with a turnaround time of the microfluidic chip was approximately 2 hours, much shorter than the conventional DST method.Conclusion: The proposed microfluidic-based KASP assay provides a cost-effective and convenient method for detecting mutations associated with drug resistance in M. tuberculosis. It represents a promising alternative to the traditional DST method, with satisfactory sensitivity and specificity and a much shorter turnaround time.

Molecular Detection of Mutations in Isolates of Multidrug Resistant Tuberculosis and Tuberculosis Suspects by Multiplex Allele Specific PCR

Molecular Detection of Isoniazid, Rifampin and Ethambutol Resistance to M. Tuberculosis and M. Bovis in Multidrug Resistant Tuberculosis (MDR-TB) Patients in Pakistan.

Early detection of MDR Mycobacterium tuberculosis mutations in Pakistan

Establishment and Application of Multi-Pcr-sscp Assay for Rapid Detection of Isoniazid- and Rifampin-Resistance Mycobacterium Tuberculosis Isolates

Accurate and affordable detection of rifampicin and isoniazid resistance in Tuberculosis sputum specimens by multiplex PCR-multiple probes melting analysis

Multi-drug resistant gene mutation analysis in Mycobacterium tuberculosis by molecular techniques

Simultaneous Detection for Isoniazid and Rifampin-Resistanct Mycobacterium Tuberculosis by Multiplex Allele-Specific PCR Assay

Detection of katG, inhA and ahpC gene mutation in clinical isolates of isoniazid-resistant Mycobacterium tuberculosis in Makassar City, South Sulawesi, Indonesia

Using Microfluidic Chip and Allele-Specific PCR to Rapidly Identify Drug Resistance-Associated Mutations of Mycobacterium tuberculosis

[A new multiplex allele-specific polymerase chain reaction assay for detection of rifampin-resistant Mycobacterium tuberculosis]

Sequence Analysis of the Rifampicin Resistance Determining Region (RRDR) of Rpob Gene in Multidrug Resistance Confirmed and Newly Diagnosed Tuberculosis Patients of Punjab, Pakistan

Experimental platform utilising melting curve technology for detection of mutations in Mycobacterium tuberculosis isolates

Pyrosequencing for rapid detection of Tuberculosis resistance in clinical isolates and Sputum samples from re-treatment Pulmonary Tuberculosis patients

Multiplex Real-Time PCR Melting Curve Assay to Detect Drug-Resistant Mutations of Mycobacterium Tuberculosis

Multi-Fluorescence Real-Time PCR Assay for Detection of RIF and INH Resistance of M. Tuberculosis

Molecular identification of multiple drug resistance (MDR) strain of Mycobacterium tuberculosis

The Pnca Gene Mutations of Mycobacterium Tuberculosis in Multidrug-Resistant Tuberculosis

Molecular Detection of Multi-drug resistant tuberculosis in clinical isolates from two urban centres in Malawi

Rapid detection of drug-resistant Mycobacterium tuberculosis by Modified MODS assay suitable for resource-poor settings

Dual Channel Real-Time PCR Melting Curve Analysis-Based Assay for Detecting of Anti-Tuberculosis Drugresistant Mutations in Mycobacterium Tuberculosis

Synergy of Xpert (MTB/RIF) and Line probe assay for detection of rifampicin resistant strains of Mycobacterium tuberculosis